Meet the Partner: PHAZE Clinical Research & Pharma Consulting S.A.
Meet PHAZE, the Contract Research Organization leading ThrombUS+’s clinical validation across Greece, Italy, France, and Lithuania, from ethics approval to GCP-compliant multi-site coordination.
ThrombUS+ Hosts Conference in Thessaloniki
Recap of the first ThrombUS+ scientific conference on DVT detection, held at Papageorgiou General Hospital in Thessaloniki, featuring a live prototype demonstration.
Meet the Partner: MEDEA S.r.l.
MEDEA S.r.l. is the ThrombUS+ partner leading exploitation strategy, IP management, and impact assurance to bring AI-powered DVT monitoring technology to market.
Meet the Partner: VDE
Meet VDE, ThrombUS+’s regulatory partner. Learn how VDE is embedding compliance-by-design into the development of an AI-powered wearable for early DVT detection.
Meet the Partner: Hôpital Simone Veil
Hôpital Simone Veil, the only French partner in ThrombUS+, brings cutting-edge venous thrombosis research and emergency medicine expertise to the consortium.
Building a Compliant AI Medical Device: Regulatory Insights from Thorsten Prinz
How do you build an AI medical device that meets EU MDR and AI Act requirements? Regulatory expert Thorsten Prinz of ThrombUS+ partner VDE explains the roadmap to compliance.
Meet the Partner: Casa Sollievo della Sofferenza
Founded by Saint Pio in 1956, Casa Sollievo della Sofferenza combines compassionate care and scientific excellence. Now a leading Italian Research Hospital (IRCCS), it contributes specialized expertise in pregnancy-related thrombosis to the ThrombUS+ European Project.
ThrombUS+ Year in Review
Tasked with creating a novel device for the early detection of DVT, ThrombUS+ made great strides in 2025 including new prototypes, the initiation of clinical trials, and advancements in scientific research.